GlassScriptPhysician profile
Neeta Rekhi
NPI 1265492573
$4,477.81
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,823 · 2020: $634 · 2021: $20.00.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,064.42 | 2019-2020 | |
| Amarin Pharma, INC. | $712.32 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $441.81 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $420.52 | 2019-2020 | |
| Novo Nordisk INC | $301.18 | 2019-2020 | |
| Abbvie INC. | $256.72 | 2019 | |
| Glaxosmithkline, LLC. | $252.97 | 2019-2020 | |
| Lilly USA, LLC | $200.69 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $168.09 | 2019-2020 | |
| Pfizer INC. | $140.06 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $133.85 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $125.76 | 2019-2020 | |
| Astellas Pharma US INC | $54.30 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.49 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.34 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $27.30 | 2019 | |
| Therapeuticsmd, INC. | $20.72 | 2019 | |
| Bardy Diagnostics, INC. | $20.00 | 2021 | |
| Seqirus USA INC | $18.45 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $18.21 | 2019 | |
| Genentech USA, INC. | $16.74 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.87 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neeta Rekhi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.